Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett's esophagus: a population-based study.
about
Update on management of Barrett's esophagusEpidemiology of Barrett's Esophagus and Esophageal AdenocarcinomaRecent developments in pathogenesis, diagnosis and therapy of Barrett's esophagusBOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia.Cost-effectiveness of chemoprevention with proton pump inhibitors in Barrett's esophagus.Alcohol consumption and the neoplastic progression in Barrett's esophagus: a systematic review and meta-analysis.Statins are associated with reduced risk of esophageal cancer, particularly in patients with Barrett's esophagus: a systematic review and meta-analysis.Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysisBritish Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus.The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett's esophagusComparative acceptability of transnasal esophagoscopy and esophageal capsule esophagoscopy: a randomized, controlled trial in veteransScreening for Barrett's esophagus and esophageal adenocarcinoma: rationale, recent progress, challenges, and future directions.Screening for Barrett's esophagus: results from a population-based surveyA randomized comparative effectiveness trial of novel endoscopic techniques and approaches for Barrett's esophagus screening in the community.Population screening for barrett esophagus: a prospective randomized pilot studyImprovement over time in outcomes for patients undergoing endoscopic therapy for Barrett's oesophagus-related neoplasia: 6-year experience from the first 500 patients treated in the UK patient registryRadiofrequency Ablation Is Associated With Decreased Neoplastic Progression in Patients With Barrett's Esophagus and Confirmed Low-Grade DysplasiaDietary fruit, vegetable, fat, and red and processed meat intakes and Barrett's esophagus risk: a systematic review and meta-analysis.Proton Pump Inhibitors Do Not Reduce the Risk of Esophageal Adenocarcinoma in Patients with Barrett's Esophagus: A Systematic Review and Meta-Analysis.Yield of Repeat Endoscopy in Barrett's Esophagus with No Dysplasia and Low-Grade Dysplasia: A Population-Based Study.Quality indicators for the management of Barrett's esophagus, dysplasia, and esophageal adenocarcinoma: international consensus recommendations from the American Gastroenterological Association SymposiumRisk of malignant progression in Barrett's esophagus patients: results from a large population-based studyRates and predictors of progression to esophageal carcinoma in a large population-based Barrett's esophagus cohort.Diagnosis and management of Barrett's esophagus.Metabolic syndrome as a risk factor for Barrett esophagus: a population-based case-control study.The characterization of an intestine-like genomic signature maintained during Barrett's-associated adenocarcinogenesis reveals an NR5A2-mediated promotion of cancer cell survival.Role of chemoprophylaxis with either NSAIDs or statins in patients with Barrett's esophagus.Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process.Review on novel concepts of columnar lined esophagus.Progression of Barrett oesophagus: role of endoscopic and histological predictors.Surveillance for low-grade dysplastic Barrett's oesophagus: one size fits all?Barrett's oesophagus patients with low-grade dysplasia can be accurately risk-stratified after histological review by an expert pathology panel.Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma.The Genetics of Barrett's Esophagus: A Familial and Population-Based Perspective.What Makes an Expert Barrett's Histopathologist?Cancer incidence and mortality risks in a large US Barrett's oesophagus cohort.Barrett's oesophagus: Current controversies.Diagnosis and management of Barrett's metaplasia: What's newThe dose of omeprazole required to achieve adequate intraesophageal acid suppression in patients with gastroesophageal junction specialized intestinal metaplasia and Barrett's esophagus.Gastroparesis on the rise: incidence vs awareness?
P2860
Q26751160-2F4DFA7E-C8EC-4E3E-8C65-37109AB821B6Q26825742-4EBB9D6F-741E-4F40-AC0C-D31F5B50549EQ26864783-C90BA79D-AEBF-483F-A5CB-C25628C6C0DBQ27332349-E310325F-5070-4BE3-B16C-BCBE18A845D4Q30619561-3AAD7497-6826-406B-BAF7-6202BD0D2D71Q34315153-A359337F-F9D5-40C1-B0AA-3CE8BF16CAE4Q34324864-A970758E-9936-4B53-B9D1-00BDB1E4E227Q34352867-9585F76C-D062-4D81-9CB5-34628D60D3C8Q34380645-A27AB451-24FE-4658-8E7E-EF10388CAC3DQ34542075-028DE1EB-499C-4A79-9DD2-105CCB11768FQ34603498-19C26387-3796-40D2-86BD-A77C93046DF1Q34624586-5BB7E79E-8C3B-4710-8EC0-07BF8E3073AAQ35291906-196300C3-98D0-4EC1-AD1B-40E25158CD54Q35291922-4AD73D6F-65DC-4FAA-9A1C-59596D6F4592Q35586353-73D56BCF-D078-4C64-AD9C-4010B23C0657Q35891829-615F170C-C066-471F-8831-793F08F9963FQ35998193-EE4ED37C-799E-4518-8AE5-F55B7A99836AQ36038972-C5A9FF65-4D16-42E3-8E80-61EE0F93D04CQ36245569-A184985E-3304-4AD4-8E03-7E36EC2D5D13Q36264943-01999F35-A5B0-476C-80BB-31368BA69837Q36764087-7B2ADFFE-5A53-433F-8745-2178513060A9Q36783294-62D52A11-20D9-470F-BDFA-E33BABAE0F08Q37018314-519576D4-CAE2-45C7-B4BC-CAB38325D947Q37055792-142284A2-D256-4C66-9AFA-D8939A398323Q37166908-8657569B-D6CA-4666-A380-9DE08EF8098CQ37227732-2C19DACE-B5B0-4F39-8E31-BF31B90DEA67Q37621036-7604FF8C-0C80-451C-9D75-A0AB5A1A1C6DQ38005810-D9E08EF8-82D0-40D5-81B2-5A90235692C6Q38141855-40F0048A-9D86-414B-87B7-17EFE85CDCA4Q38214785-DD99A159-E0DE-46FB-BF83-01E6EE71F8B3Q38219587-A926F68F-DAF9-4EF0-9588-189DBAC51501Q38230762-D2E9D69D-108E-4261-959B-D51842C0BA40Q38328606-FD81384B-1483-4A37-91A1-1A1C5ED10C39Q38771931-5206A4B1-A3BC-46B5-BAF7-CFB2A1609FE2Q38940516-9B8AD9B9-6235-4153-BCA3-998C22740FD1Q40396082-4295FEED-CD54-43ED-8139-261CD7292B31Q41191034-00BB899A-CBAE-4FD6-87E5-E3BEC0B3BC84Q41550041-68B022A1-AAEC-40D6-8965-78B636590A7EQ43756856-D6A8B385-BCDC-400B-8AD8-A8CF0ED876A3Q44629348-9C233BFA-992C-4CDF-AB8E-E1997703E814
P2860
Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett's esophagus: a population-based study.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Epidemiology and natural histo ...... gus: a population-based study.
@ast
Epidemiology and natural histo ...... gus: a population-based study.
@en
type
label
Epidemiology and natural histo ...... gus: a population-based study.
@ast
Epidemiology and natural histo ...... gus: a population-based study.
@en
prefLabel
Epidemiology and natural histo ...... gus: a population-based study.
@ast
Epidemiology and natural histo ...... gus: a population-based study.
@en
P2093
P2860
P356
P1476
Epidemiology and natural histo ...... gus: a population-based study.
@en
P2093
Cathy D Schleck
David A Katzka
Debra M Geno
G Richard Locke
Ganapathy A Prasad
Kee Wook Jung
Kelly T Dunagan
Kenneth K Wang
Lori S Lutzke
Mary Frederickson
P2860
P304
1447-55; quiz 1456
P356
10.1038/AJG.2011.130
P407
P577
2011-04-12T00:00:00Z